Advertisement

Related Videos

Varsha Gandhi, PhD, on Ibrutinib

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Amit Sanyal, MD: A Clinician’s Perspective

Advertisement

Advertisement




May
28
Today In Oncology
BPDCN FDA Approves Pivekimab Sunirine-pvzy
After the Founder: What a Cervical Cancer Program in Haiti Teaches About Sustaining Prevention
Off-the-Shelf CAR T-Cell Therapy Produces Deep, Durable Responses in Heavily Pretreated Multiple Myeloma
Sonrotoclax Receives Accelerated Approval in Relapsed or Refractory MCL
Early Breast Cancer Is Surgery Omission Possible Following Estrogen and Ablative Radiation Therapy
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo